- Email: [email protected]
Scientific Program
International Journal of Infectious Diseases (2008) 12(S3) vii–xiv
Scientific Program as of 23 October, 2008 14 NOVEMBER 2008, FRIDAY
14:00-16:05
Meeting Room 201
Bilateral Scientific & Technological Cooperation Belgium-China Biomarker of Liver Fibrosis and Liver Cancer: From Molecular Biology to Clinical Perspectives
Chairpersons: Hui Zhuang (
), Beijing
Claude Libert, Ghent, Belgium Non-Invasive (Serum) Markers in the Diagnosis of Liver Fibrosis Hans Van Vlierberghe, Ghent, Belgium Insight into New Markers and Diagnostic Models on Hapatocellelar Carcinoma Chunfang Gao ( ), Shanghai The Ras Inhibitor Farnesylthiosalicyclic Acid (FTS) Prevents Nodule Formation and Development of Preneoplastic Foci of Altered Hepatocytes in Rats Yves Horsman, Bruxelles, Belgium Blood Sugar Test: Non-Invasive Diagnosis for Liver Diseases Chitty Chen, Ghent, Belgium HBV Genome Oncogenic Mutations in Chinese HCC Related to Chronic HBV Infection ), Beijing Fengmin Lu ( 16:05-16:30 16:30-18:05
Coffee break Meeting Room 201
A Review for Liver Transplantation in China Shichun Lu ( ), Beijing Risks and results of the living related liver transplantation in Europe Bernard de Hemptinne, Ghent, Belgium Shear Stress: A Trigger for Liver Regeneration Cascade? Yedong Fan, Ghent, Belgium Contrast Enhanced Magnetic Resonance Imaging as Virtual Biopsy for Diagnosis and Therapeutic Assessment of Liver Malignancies Yicheng Ni, Leuven, Belgium
viii
Scientific Program
15 NOVEMBER 2008, SATURDAY
08:00-08:30
Convention Hall 2
Presidential Lecture 1 The Construction and Development of New Type Infectious Hospital ), Beijing Yu Mao (
08:30-08:45 08:45-10:00
BREAK Convention Hall 2
Concurrent Session 1 - Management of Hepatitis B Occult HBV Infection Shiv K. Sarin, New Delhi, India Treatment of Hepatitis B Virus Masao Omata, Tokyo, Japan From the Pathogenesis to the Therapeutic Strategy of Chronic Hepatitis B Infection Guiqiang Wang ( ), Beijing
10:00-10:45
Convention Hall 2
Industry Supported Satellite Symposium (GSK)
08:45-10:45
Meeting Room 201
Concurrent Session 2 - Bacterial Infection Prevalence of dupA of Helicobacter Pylori Strains Isolated from Shanghai Patients and Its Clinical Implications ), Shanghai Hong Lu ( Antimicrobial Susceptibility Testing through EUCAST Gunnar Kahlmeter, Vaxjo, Sweden Laribacter Hongkongensis: From Discovery to Complete Genome Sequence ), Hong Kong Patrick C.Y. Woo ( Antibiotic Resistance in Gram-Negative Pathogens: Dealing with Untreatable Infections Paul A. Tambyah, Singapore Two Stage Theory Pathogenic Mechanism of Streptococcus suis Jianguo Xu ( ), Beijing
08:45-10:45
Meeting Room 311
Concurrent Session 3 - HIV – Overview Prevalence of Drug Resistance HIV-1 in Rural Areas of Hubei Province in the People’s Republic of China Zhiwei Chen ( ), Hong Kong Molecular Epidemiology of Drug Resistant HIV-1 in Hong Kong ), Hong Kong Wing-Cheong Yam ( Opportunistic Infections in AIDS : Thai Experience Boonmee Sathapatayavongs, Bangkok, Thailand HIV-Specific T-Cell Responses in a Cohort of Slow Progressors in China Tao Dong, Oxford, United Kingdom Outcomes and Challenges of the China National Free Antiretroviral Treatment Program ), Beijing Fujie Zhang (
10:45-11:15 11:15-11:30
Meeting Room 201
Plenary Session 1 BREAK
Scientific Program
ix
11:30-13:00
Convention Hall 2
Industry Supported Satellite Symposium (BMS)
13:00-13:30
Convention Hall 2
Presidential Lecture 2 Overview of MRSA Giuseppe Cornaglia, Verona, Italy
13:30-15:30
Convention Hall 2
Concurrent Session 4 - Immunology and Virology The Immunology of HBV Infection John M. Vierling, Houston, United States Virologic Techniques for the Diagnosis and Monitoring of Hepatitis B ), Hong Kong George K.K. Lau ( New Cell Culture and Mouse Models of HBV Replication ), Chengdu Hong Tang ( Association between Epidermal Growth Factor Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus Chronic Infection Fengmin Lu ( ), Beijing The Natural History of Infections Caused by Varicella-Zoster Virus (VZV): Primary Infection, Transmission, Latency, and Reactivation Michael D. Gershon, New York, United States
13:30-15:30
Meeting Room 201
Concurrent Session 5 - Usage of Antibiotics and MRSA Antibiotic Application in China ), Beijing Yonghong Xiao ( Prenyltransferases as Targets for Antibiotic Drug Discovery ), Taipei Andrew H.J. Wang ( Antibiotic Use and Epidemiology Characteristic of Methicillin-Resistant Staphylococcus aureus in Chinese Pediatrics Xuzhuang Shen ( ), Beijing Molecular Identification and Typing of Methicillin-Resistant Staphylococcus aureus (MRSA) Margaret Ip ( ), Hong Kong Resistance in S. aureus: Should Epidemiology Patterns Influence the Hui Choice of Therapy? Hui Wang ( ), Beijing
13:30-15:30
Meeting Room 311
Concurrent Session 6 - Tuberculosis Updates Extensively Drug Resistant Tuberculosis (XDR-TB) – An Overview Robert C. Read, Sheffield, United Kingdom Latent Infection of M. Tuberculosis in China ), Shanghai Wenhong Zhang ( Epidemiology of Mycobacterium Tuberculosis Genotypes in Different Ethnic and Age Populations in Taiwan Ih-Jen Su ( ), Tainan Recent Advances in the Diagnosis of TB Giorgio Roscigno, Geneva, Switzerland Molecular Diagnosis of Tuberculosis Sang Nae Cho, Seoul, Korea Detection of Mycobacterium tuberculosis infection using Interferon-Gamma Release Assay in Shenzhen, China Xinchun Chen ( ), Shenzhen
15:30-16:00
Convention Hall 2
Presidential Lecture 3
x
Scientific Program
Towards an HIV Vaccine - What is Protective Immunity against HIV Infection? Sarah Rowland-Jones, Oxford, United Kingdom 16:00-17:30
Meeting Room 201A
Free Paper Presentation 1 – Tuberculosis
16:00-17:30
Meeting Room 201B
Free Paper Presentation 2 – Hepatitis B
16:00-17:30
Meeting Room 311C
Free Paper Presentation 3 – Basic Science and Animal Models
17:30-18:30
Convention Hall 2
Industry Supported Satellite Symposium (Schering Plough) 16 NOVEMBER 2008, SUNDAY
08:00-08:30
Convention Hall 2
Presidential Lecture 4 Vaccination against Varicella and Zoster: History and Experience in the United States Anne A. Gershon, New York, United States
08:30-08:45 08:45-10:45
BREAK Convention Hall 2
Concurrent Session 7 - Understanding HCV Pathogenesis and Clinical Impact of Insulin Resistance in HCV Infection Alfredo Alberti, Padova, Italy Regulation of a Hepatitis C Virus Co-Receptor Claudin-1 in Hepatocytes Takashi Kojima, Sapporo, Japan Assessment of Specific Antibodies to F Protein in Sera of Chinese Hepatitis C Patients Treated with Interferon plus Ribavarin Xinxin Zhang ( ), Shanghai Efficacy and Relapse: Peginterferon Alpha-2a plus Ribavirin Combination Therapy in Chinese Patients with Chronic Hepatitis C in Clinical Practice Xiaoguang Dou ( ), Shenyang
08:45-10:45
Meeting Room 201
Concurrent Session 8 - Nosocomial Infection and Public Health Rational Management of Community Acquired Pneumonia ), Hong Kong Bing Lam ( Clinical Management of Severe Respiratory Infections in Adult Hospitalized Patients Nelson L.S. Lee ( ), Hong Kong Creative Hand Hygiene Campaigns Moi-Lin Ling, Singapore The Clinical Characteristics and Therapy for SARS ), Beijing Limin Guo ( Strategy for Recalcitrant MRSA Infections - An Evolving Clinical Challenge Po-Ren Hsueh ( ), Taipei
08:45-10:45
Meeting Room 311
Concurrent Session 9 – End-Stage Liver Diseases and Complications Cirrhotic Cardiomyopathy: An Unappreciated Complication of End-Stage Liver Disease
Scientific Program
xi
Samuel S. Lee, Calgary, Canada Infectious Complications in Acute Liver Failure Vikram Bhatia, New Delhi, India TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Treatment of Complications of Portal Hypertension Duncan M. Brooks, Heidelberg, Australia fgl2 Molecule, Micro-Circulation Disorder and Infectious Diseases ), Wuhan Qin Ning ( TBC ), Chongqing Yuming Wang (
10:45-11:15
Meeting Room 201
11:15-11:30
Plenary Session 2 BREAK
11:30-13:00
Convention Hall 2
Industry Supported Satellite Symposium (Novartis)
13:00-13:30
Convention Hall 2
Presidential Lecture 5 Pathogenesis and Treatment of Bird Flu Kwok-Yung Yuen ( ), Hong Kong
13:30-15:30
Convention Hall 2
Concurrent Session 10 - Management of Hepatitis C Treatment of Chronic Hepatitis C in Taiwan Jia-Horng Kao ( ), Taipei Optimizing HCV Antiviral Treatment: Reducing Treatment Duration Samuel S. Lee, Calgary, Canada Optimizing HCV Antiviral Treatment: Lengthening Treatment Duration Lai Wei ( ), Beijing TBC ), Chongqing Hong Ren ( Management of Chronic Hepatitis B and C in HIV-Coinfected Patients Teerha Piratvisuth, Hat Yai, Thailand
13:30-15:30
Meeting Room 201
Concurrent Session 11 – Emerging Infectious Diseases: Pathogen in Animal and Human Death and Severity of Meningococcal Disease - Influence of Microbial Phenotype, Host Genotype and Environment Robert C. Read, Sheffield, United Kingdom Emerging Bartonella in Animal and Human in China Qiyong Liu ( ), Beijing More and More Human and Animal Coronaviruses ), Hong Kong Patrick C.Y. Woo ( The Interaction between M1 Protein of Influenza Virus and Host Cell Factors Wenjun Liu ( ), Beijing Structural Study of RNA Polymerase PA Subunit from an Avian Influenza Virus Yingfang Liu ( ), Beijing
13:30-15:30
Meeting Room 311
Concurrent Session 12 - Vaccination: Prevention and Beyond
xii
Scientific Program
The Changing Molecular Epidemiology of Hepatitis A Virus Infection in Jerusalem Following Implementation of Universal Vaccination in 1999-2004 Daniel Shouval, Jerusalem, Israel Epidemiology and Prevention of HPV Related Diseases in China Youlin Qiao ( ), Beijing Development of Therapeutic Vaccine against HBV by the Use of Adjuvant to Boost the Cell-Mediated Immunity ), Beijing Bin Wang ( Sequential Vaccination with Heterolgous HIV immunogens stimulate cross-reative T-cell and neutralization antibodies Jianqing Xu ( ), Shanghai
15:30-16:30
BREAK and POSTER SESSION
16:30-18:00
Meeting Room 201A
Free Paper Presentation 4 – Infectious Diseases and Public Health
16:30-18:00
Meeting Room 201B
Free Paper Presentation 5 – HIV/AIDS and Viral Infection
16:30-18:00
Meeting Room 311C
Free Paper Presentation 6 – Hepatitis C
17 NOVEMBER 2008, MONDAY
08:00-08:45
Meeting Room 201
Plenary Session 3
08:45-10:45
Convention Hall 2
Concurrent Session 13 - Viral Hepatitis and Hepatocellular Carcinoma Viral Factors of Hepatocellular Carcinoma in Chronic Hepatitis B ), Hong Kong Henry L.Y. Chan ( Hepatitis B and C Viral-Cellular Interactions in the Pathogenesis of Hepatocellular Carcinoma Jack R. Wands, Providence, United States How to Predict HCC Development in Patients with Chronic Hepatitis B Viral Infection? Kwang Hyub Han, Seoul, Korea
08:45-10:45
Meeting Room 201
Concurrent Session 14 - Fungal Infection Fungal Infections: Insights from the Bench-Side Mamie Hui ( ), Hong Kong Invasive Fungal Infections in Asia-Pacific Region Po-Ren Hsueh ( ), Taipei Genotype Distribution of Candida Albicans in China ), Beijing Fengyan Bai ( Non-Culture Diagnosis of Fungal Infection ), Beijing Ruoyu Li ( Systemic Mycoses of Local Importance Boonmee Sathapatayavongs, Bangkok, Thailand
08:45-10:45
Meeting Room 311
Concurrent Session 15 - HIV / AIDS Treatment - Never Simple The Changes and Distributions Status of Opportunistic Infections during 6 months after HAART Initiation
Scientific Program
xiii
), Beijing Hongxin Zhao ( Salvage Antiretroviral Regimens in the Resource Limited Settings Christopher K.C. Lee, Sungai Buloh, Malaysia Practice Guidelines for the Management of Patients with AIDS and Cryptococcal Meningitis ), Shanghai Hongzhou Lu ( Specific T-cell Responses to ESAT-6 and CFP-10 in Chinese HIV Positive Individuals without Active TB Disease. A Way to Find the Latent TB Infection in China? ), Beijing Wenhui Lun (
10:45-11:15
Meeting Room 201
11:15-11:30
Plenary Session 4 BREAK
11:30-13:00
Convention Hall 2
Industry Supported Satellite Symposium (Roche)
13:00-13:30
Convention Hall 2
Presidential Lecture 6 Viral Hepatitis B: Where We Are and Where We Are Going ), Beijing Jidong Jia (
13:30-15:30
Convention Hall 2
Concurrent Session 16 - Advanced Treatment Strategies of Hepatitis B New Paradigms for the Treatment of Hepatitis B Morris Sherman, Toronto, Canada The Host Immunity Response of Hepatitis B Patients After Adefovir Dipivoxil and Entecavir Therapy ), Changchun Junqi Niu ( How to Manage and Prevent Drug Resistant HBV ), Hong Kong Richard M.F. Yuen (
13:30-15:30
Meeting Room 201
Concurrent Session 17 - Parasitology and Tropical Medicine New Developments in the Pathophysiology and Diagnosis of Dengue Fever and its Complications Vincent T.K. Chow, Singapore Temporal-Spatial Analysis of Dengue Fever Epidemic in Guangdong Province of China, 2001-2006 ), Beijing Qiyong Liu ( Phylogenic status of Pneumocystis Derived from Mongolian Gerbil ), Beijing Siqi Lu ( Proteomic Analysis of CSF in Patients with Neurocysticercosis ), Beijing Yanping Xue ( TBC Linhua Tang ( ), Shanghai
13:30-15:30
Meeting Room 311
Concurrent Session 18 – Biotechnology: From the Micro-world to Real-world A New Mouse Model for Investigating Tolerance to Hepatitis B Virus: The Important Role of HBV Core Protein ), Taipei Pei-Jer Chen ( Gene Therapy of Chronic Hepadnavirus Infection Jesus Prieto, Pamplona, Spain Increased Regulatory T Cells Impair Adaptive Immunity and Favor
xiv
Scientific Program
Disease Progression in Chronic HBV-infected Patients Fusheng Wang ( ), Beijing The Evolution of the Innate Immune System: T Cells Are Required for Homeostatic Innate Inflammatory Response to Viral Infection Hong Tang ( ), Beijing TBC ), Beijing Jinming Li (
Scientific Program as of 23 October, 2008 14 NOVEMBER 2008, FRIDAY
14:00-16:05
Meeting Room 201
Bilateral Scientific & Technological Cooperation Belgium-China Biomarker of Liver Fibrosis and Liver Cancer: From Molecular Biology to Clinical Perspectives
Chairpersons: Hui Zhuang (
), Beijing
Claude Libert, Ghent, Belgium Non-Invasive (Serum) Markers in the Diagnosis of Liver Fibrosis Hans Van Vlierberghe, Ghent, Belgium Insight into New Markers and Diagnostic Models on Hapatocellelar Carcinoma Chunfang Gao ( ), Shanghai The Ras Inhibitor Farnesylthiosalicyclic Acid (FTS) Prevents Nodule Formation and Development of Preneoplastic Foci of Altered Hepatocytes in Rats Yves Horsman, Bruxelles, Belgium Blood Sugar Test: Non-Invasive Diagnosis for Liver Diseases Chitty Chen, Ghent, Belgium HBV Genome Oncogenic Mutations in Chinese HCC Related to Chronic HBV Infection ), Beijing Fengmin Lu ( 16:05-16:30 16:30-18:05
Coffee break Meeting Room 201
A Review for Liver Transplantation in China Shichun Lu ( ), Beijing Risks and results of the living related liver transplantation in Europe Bernard de Hemptinne, Ghent, Belgium Shear Stress: A Trigger for Liver Regeneration Cascade? Yedong Fan, Ghent, Belgium Contrast Enhanced Magnetic Resonance Imaging as Virtual Biopsy for Diagnosis and Therapeutic Assessment of Liver Malignancies Yicheng Ni, Leuven, Belgium
viii
Scientific Program
15 NOVEMBER 2008, SATURDAY
08:00-08:30
Convention Hall 2
Presidential Lecture 1 The Construction and Development of New Type Infectious Hospital ), Beijing Yu Mao (
08:30-08:45 08:45-10:00
BREAK Convention Hall 2
Concurrent Session 1 - Management of Hepatitis B Occult HBV Infection Shiv K. Sarin, New Delhi, India Treatment of Hepatitis B Virus Masao Omata, Tokyo, Japan From the Pathogenesis to the Therapeutic Strategy of Chronic Hepatitis B Infection Guiqiang Wang ( ), Beijing
10:00-10:45
Convention Hall 2
Industry Supported Satellite Symposium (GSK)
08:45-10:45
Meeting Room 201
Concurrent Session 2 - Bacterial Infection Prevalence of dupA of Helicobacter Pylori Strains Isolated from Shanghai Patients and Its Clinical Implications ), Shanghai Hong Lu ( Antimicrobial Susceptibility Testing through EUCAST Gunnar Kahlmeter, Vaxjo, Sweden Laribacter Hongkongensis: From Discovery to Complete Genome Sequence ), Hong Kong Patrick C.Y. Woo ( Antibiotic Resistance in Gram-Negative Pathogens: Dealing with Untreatable Infections Paul A. Tambyah, Singapore Two Stage Theory Pathogenic Mechanism of Streptococcus suis Jianguo Xu ( ), Beijing
08:45-10:45
Meeting Room 311
Concurrent Session 3 - HIV – Overview Prevalence of Drug Resistance HIV-1 in Rural Areas of Hubei Province in the People’s Republic of China Zhiwei Chen ( ), Hong Kong Molecular Epidemiology of Drug Resistant HIV-1 in Hong Kong ), Hong Kong Wing-Cheong Yam ( Opportunistic Infections in AIDS : Thai Experience Boonmee Sathapatayavongs, Bangkok, Thailand HIV-Specific T-Cell Responses in a Cohort of Slow Progressors in China Tao Dong, Oxford, United Kingdom Outcomes and Challenges of the China National Free Antiretroviral Treatment Program ), Beijing Fujie Zhang (
10:45-11:15 11:15-11:30
Meeting Room 201
Plenary Session 1 BREAK
Scientific Program
ix
11:30-13:00
Convention Hall 2
Industry Supported Satellite Symposium (BMS)
13:00-13:30
Convention Hall 2
Presidential Lecture 2 Overview of MRSA Giuseppe Cornaglia, Verona, Italy
13:30-15:30
Convention Hall 2
Concurrent Session 4 - Immunology and Virology The Immunology of HBV Infection John M. Vierling, Houston, United States Virologic Techniques for the Diagnosis and Monitoring of Hepatitis B ), Hong Kong George K.K. Lau ( New Cell Culture and Mouse Models of HBV Replication ), Chengdu Hong Tang ( Association between Epidermal Growth Factor Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus Chronic Infection Fengmin Lu ( ), Beijing The Natural History of Infections Caused by Varicella-Zoster Virus (VZV): Primary Infection, Transmission, Latency, and Reactivation Michael D. Gershon, New York, United States
13:30-15:30
Meeting Room 201
Concurrent Session 5 - Usage of Antibiotics and MRSA Antibiotic Application in China ), Beijing Yonghong Xiao ( Prenyltransferases as Targets for Antibiotic Drug Discovery ), Taipei Andrew H.J. Wang ( Antibiotic Use and Epidemiology Characteristic of Methicillin-Resistant Staphylococcus aureus in Chinese Pediatrics Xuzhuang Shen ( ), Beijing Molecular Identification and Typing of Methicillin-Resistant Staphylococcus aureus (MRSA) Margaret Ip ( ), Hong Kong Resistance in S. aureus: Should Epidemiology Patterns Influence the Hui Choice of Therapy? Hui Wang ( ), Beijing
13:30-15:30
Meeting Room 311
Concurrent Session 6 - Tuberculosis Updates Extensively Drug Resistant Tuberculosis (XDR-TB) – An Overview Robert C. Read, Sheffield, United Kingdom Latent Infection of M. Tuberculosis in China ), Shanghai Wenhong Zhang ( Epidemiology of Mycobacterium Tuberculosis Genotypes in Different Ethnic and Age Populations in Taiwan Ih-Jen Su ( ), Tainan Recent Advances in the Diagnosis of TB Giorgio Roscigno, Geneva, Switzerland Molecular Diagnosis of Tuberculosis Sang Nae Cho, Seoul, Korea Detection of Mycobacterium tuberculosis infection using Interferon-Gamma Release Assay in Shenzhen, China Xinchun Chen ( ), Shenzhen
15:30-16:00
Convention Hall 2
Presidential Lecture 3
x
Scientific Program
Towards an HIV Vaccine - What is Protective Immunity against HIV Infection? Sarah Rowland-Jones, Oxford, United Kingdom 16:00-17:30
Meeting Room 201A
Free Paper Presentation 1 – Tuberculosis
16:00-17:30
Meeting Room 201B
Free Paper Presentation 2 – Hepatitis B
16:00-17:30
Meeting Room 311C
Free Paper Presentation 3 – Basic Science and Animal Models
17:30-18:30
Convention Hall 2
Industry Supported Satellite Symposium (Schering Plough) 16 NOVEMBER 2008, SUNDAY
08:00-08:30
Convention Hall 2
Presidential Lecture 4 Vaccination against Varicella and Zoster: History and Experience in the United States Anne A. Gershon, New York, United States
08:30-08:45 08:45-10:45
BREAK Convention Hall 2
Concurrent Session 7 - Understanding HCV Pathogenesis and Clinical Impact of Insulin Resistance in HCV Infection Alfredo Alberti, Padova, Italy Regulation of a Hepatitis C Virus Co-Receptor Claudin-1 in Hepatocytes Takashi Kojima, Sapporo, Japan Assessment of Specific Antibodies to F Protein in Sera of Chinese Hepatitis C Patients Treated with Interferon plus Ribavarin Xinxin Zhang ( ), Shanghai Efficacy and Relapse: Peginterferon Alpha-2a plus Ribavirin Combination Therapy in Chinese Patients with Chronic Hepatitis C in Clinical Practice Xiaoguang Dou ( ), Shenyang
08:45-10:45
Meeting Room 201
Concurrent Session 8 - Nosocomial Infection and Public Health Rational Management of Community Acquired Pneumonia ), Hong Kong Bing Lam ( Clinical Management of Severe Respiratory Infections in Adult Hospitalized Patients Nelson L.S. Lee ( ), Hong Kong Creative Hand Hygiene Campaigns Moi-Lin Ling, Singapore The Clinical Characteristics and Therapy for SARS ), Beijing Limin Guo ( Strategy for Recalcitrant MRSA Infections - An Evolving Clinical Challenge Po-Ren Hsueh ( ), Taipei
08:45-10:45
Meeting Room 311
Concurrent Session 9 – End-Stage Liver Diseases and Complications Cirrhotic Cardiomyopathy: An Unappreciated Complication of End-Stage Liver Disease
Scientific Program
xi
Samuel S. Lee, Calgary, Canada Infectious Complications in Acute Liver Failure Vikram Bhatia, New Delhi, India TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Treatment of Complications of Portal Hypertension Duncan M. Brooks, Heidelberg, Australia fgl2 Molecule, Micro-Circulation Disorder and Infectious Diseases ), Wuhan Qin Ning ( TBC ), Chongqing Yuming Wang (
10:45-11:15
Meeting Room 201
11:15-11:30
Plenary Session 2 BREAK
11:30-13:00
Convention Hall 2
Industry Supported Satellite Symposium (Novartis)
13:00-13:30
Convention Hall 2
Presidential Lecture 5 Pathogenesis and Treatment of Bird Flu Kwok-Yung Yuen ( ), Hong Kong
13:30-15:30
Convention Hall 2
Concurrent Session 10 - Management of Hepatitis C Treatment of Chronic Hepatitis C in Taiwan Jia-Horng Kao ( ), Taipei Optimizing HCV Antiviral Treatment: Reducing Treatment Duration Samuel S. Lee, Calgary, Canada Optimizing HCV Antiviral Treatment: Lengthening Treatment Duration Lai Wei ( ), Beijing TBC ), Chongqing Hong Ren ( Management of Chronic Hepatitis B and C in HIV-Coinfected Patients Teerha Piratvisuth, Hat Yai, Thailand
13:30-15:30
Meeting Room 201
Concurrent Session 11 – Emerging Infectious Diseases: Pathogen in Animal and Human Death and Severity of Meningococcal Disease - Influence of Microbial Phenotype, Host Genotype and Environment Robert C. Read, Sheffield, United Kingdom Emerging Bartonella in Animal and Human in China Qiyong Liu ( ), Beijing More and More Human and Animal Coronaviruses ), Hong Kong Patrick C.Y. Woo ( The Interaction between M1 Protein of Influenza Virus and Host Cell Factors Wenjun Liu ( ), Beijing Structural Study of RNA Polymerase PA Subunit from an Avian Influenza Virus Yingfang Liu ( ), Beijing
13:30-15:30
Meeting Room 311
Concurrent Session 12 - Vaccination: Prevention and Beyond
xii
Scientific Program
The Changing Molecular Epidemiology of Hepatitis A Virus Infection in Jerusalem Following Implementation of Universal Vaccination in 1999-2004 Daniel Shouval, Jerusalem, Israel Epidemiology and Prevention of HPV Related Diseases in China Youlin Qiao ( ), Beijing Development of Therapeutic Vaccine against HBV by the Use of Adjuvant to Boost the Cell-Mediated Immunity ), Beijing Bin Wang ( Sequential Vaccination with Heterolgous HIV immunogens stimulate cross-reative T-cell and neutralization antibodies Jianqing Xu ( ), Shanghai
15:30-16:30
BREAK and POSTER SESSION
16:30-18:00
Meeting Room 201A
Free Paper Presentation 4 – Infectious Diseases and Public Health
16:30-18:00
Meeting Room 201B
Free Paper Presentation 5 – HIV/AIDS and Viral Infection
16:30-18:00
Meeting Room 311C
Free Paper Presentation 6 – Hepatitis C
17 NOVEMBER 2008, MONDAY
08:00-08:45
Meeting Room 201
Plenary Session 3
08:45-10:45
Convention Hall 2
Concurrent Session 13 - Viral Hepatitis and Hepatocellular Carcinoma Viral Factors of Hepatocellular Carcinoma in Chronic Hepatitis B ), Hong Kong Henry L.Y. Chan ( Hepatitis B and C Viral-Cellular Interactions in the Pathogenesis of Hepatocellular Carcinoma Jack R. Wands, Providence, United States How to Predict HCC Development in Patients with Chronic Hepatitis B Viral Infection? Kwang Hyub Han, Seoul, Korea
08:45-10:45
Meeting Room 201
Concurrent Session 14 - Fungal Infection Fungal Infections: Insights from the Bench-Side Mamie Hui ( ), Hong Kong Invasive Fungal Infections in Asia-Pacific Region Po-Ren Hsueh ( ), Taipei Genotype Distribution of Candida Albicans in China ), Beijing Fengyan Bai ( Non-Culture Diagnosis of Fungal Infection ), Beijing Ruoyu Li ( Systemic Mycoses of Local Importance Boonmee Sathapatayavongs, Bangkok, Thailand
08:45-10:45
Meeting Room 311
Concurrent Session 15 - HIV / AIDS Treatment - Never Simple The Changes and Distributions Status of Opportunistic Infections during 6 months after HAART Initiation
Scientific Program
xiii
), Beijing Hongxin Zhao ( Salvage Antiretroviral Regimens in the Resource Limited Settings Christopher K.C. Lee, Sungai Buloh, Malaysia Practice Guidelines for the Management of Patients with AIDS and Cryptococcal Meningitis ), Shanghai Hongzhou Lu ( Specific T-cell Responses to ESAT-6 and CFP-10 in Chinese HIV Positive Individuals without Active TB Disease. A Way to Find the Latent TB Infection in China? ), Beijing Wenhui Lun (
10:45-11:15
Meeting Room 201
11:15-11:30
Plenary Session 4 BREAK
11:30-13:00
Convention Hall 2
Industry Supported Satellite Symposium (Roche)
13:00-13:30
Convention Hall 2
Presidential Lecture 6 Viral Hepatitis B: Where We Are and Where We Are Going ), Beijing Jidong Jia (
13:30-15:30
Convention Hall 2
Concurrent Session 16 - Advanced Treatment Strategies of Hepatitis B New Paradigms for the Treatment of Hepatitis B Morris Sherman, Toronto, Canada The Host Immunity Response of Hepatitis B Patients After Adefovir Dipivoxil and Entecavir Therapy ), Changchun Junqi Niu ( How to Manage and Prevent Drug Resistant HBV ), Hong Kong Richard M.F. Yuen (
13:30-15:30
Meeting Room 201
Concurrent Session 17 - Parasitology and Tropical Medicine New Developments in the Pathophysiology and Diagnosis of Dengue Fever and its Complications Vincent T.K. Chow, Singapore Temporal-Spatial Analysis of Dengue Fever Epidemic in Guangdong Province of China, 2001-2006 ), Beijing Qiyong Liu ( Phylogenic status of Pneumocystis Derived from Mongolian Gerbil ), Beijing Siqi Lu ( Proteomic Analysis of CSF in Patients with Neurocysticercosis ), Beijing Yanping Xue ( TBC Linhua Tang ( ), Shanghai
13:30-15:30
Meeting Room 311
Concurrent Session 18 – Biotechnology: From the Micro-world to Real-world A New Mouse Model for Investigating Tolerance to Hepatitis B Virus: The Important Role of HBV Core Protein ), Taipei Pei-Jer Chen ( Gene Therapy of Chronic Hepadnavirus Infection Jesus Prieto, Pamplona, Spain Increased Regulatory T Cells Impair Adaptive Immunity and Favor
xiv
Scientific Program
Disease Progression in Chronic HBV-infected Patients Fusheng Wang ( ), Beijing The Evolution of the Innate Immune System: T Cells Are Required for Homeostatic Innate Inflammatory Response to Viral Infection Hong Tang ( ), Beijing TBC ), Beijing Jinming Li (